United Therapeutics (UTHR) Stock Price, Quote, News & History

Comments

United Therapeutics Corp (UTHR) Stock Price, Quote, News & History

UTHRNASDAQ

Trade with Public

$559.65

-5.16-0.91%

At close: Apr 6, 5:00 PM EST

$559.65

N/A

After Hours: 4:26 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$566.14

Close

$559.65

Volume / Avg.

504.98K / 496.34K

Day Range

$552.54 - $567.39

52 Wk Range

266.98 - 607.89

Market Cap

$24.10B

P/E Ratio

20.27

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.81%

Days to Cover

4.09

Recent United Therapeutics Corp News

Why Is United Therapeutics Stock Soaring Monday?

United Therapeutics (UTHR) stock surges 16% premarket after Tyvaso meets primary endpoint in pivotal IPF study. Get the full breakdown.

Vandana Singh

Crude Falls Below $100 As Trump Mulls Emergency Reserve Release: What's Moving Markets Monday?

Wall Street opened the week still in negative territory as tensions in the Middle East continued to ripple across global markets.

Piero Cingari

United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening

United Therapeutics stock climbs after trial shows 55% lower risk in lung disease patients, plans FDA filing in 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.56B

Investing Cash Flow (TTM)

-551.30M

Financing Cash Flow (TTM)

-1.15B

Free Cash Flow (TTM)

1.04B

Capital Expenditure (TTM)

-526.00M

Net Change in Cash (TTM)

-140.10M

Analyst Trends and Forecast

2

Oct 25

1

Nov 25

1

Jan

4

1

Feb

4

3

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$21.41B

PE Ratio (TTM)

20.27

PE Ratio (FWD)

20.04

PEG Ratio (TTM)

2.25

PS Ratio (TTM)

8.50

PB Ratio (TTM)

3.49

Earnings Yield % (TTM)

4.93%

Earnings Yield % (FWD)

4.99%

EV / EBITDA (TTM)

11.89

Price / EBITDA (TTM)

14.87

Price / Free Cash Flow (TTM)

26.13

Book Value / Share

$161.91

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.56B

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$500.00M

Key Statistics

Open

$566.14

Close

$559.65

Volume / Avg.

504.98K / 496.34K

Day Range

$552.54 - $567.39

52 Wk Range

266.98 - 607.89

Market Cap

$24.10B

P/E Ratio

20.27

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.81%

Days to Cover

4.09

About

Sector

Health Care

Industry

Biotechnology

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy United Therapeutics (UTHR) stock?

A

You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are United Therapeutics (UTHR) competitors?

A

Other companies in United Therapeutics’s space includes: BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).

Q

What is the forecast, or price target, for United Therapeutics (UTHR) stock?

A

United Therapeutics has a consensus price target of $494.18.

Q

What is the current price for United Therapeutics (UTHR)?

A

The stock price for United Therapeutics (NASDAQ: UTHR) is $559.65 last updated April 6, 2026 at 4:26 PM EDT.

Q

Does United Therapeutics (UTHR) pay a dividend?

A

There are no upcoming dividends for United Therapeutics.

Q

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

A

United Therapeutics does not have any upcoming earnings scheduled.

Q

Is United Therapeutics (UTHR) going to split?

A

There is no upcoming split for United Therapeutics.

Q

What sector and industry does United Therapeutics (UTHR) operate in?

A

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Neurocrine Biosciences Inc

NASDAQ:NBIX

$132.48

%

Ionis Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

NASDAQ:MDGL

$533.88

%

Key Statistics

Open

$566.14

Close

$559.65

Volume / Avg.

504.98K / 496.34K

Day Range

$552.54 - $567.39

52 Wk Range

266.98 - 607.89

Market Cap

$24.10B

P/E Ratio

20.27

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.81%

Days to Cover

4.09

Recent United Therapeutics Corp News

Why Is United Therapeutics Stock Soaring Monday?

United Therapeutics (UTHR) stock surges 16% premarket after Tyvaso meets primary endpoint in pivotal IPF study. Get the full breakdown.

Vandana Singh

Crude Falls Below $100 As Trump Mulls Emergency Reserve Release: What's Moving Markets Monday?

Wall Street opened the week still in negative territory as tensions in the Middle East continued to ripple across global markets.

Piero Cingari

United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening

United Therapeutics stock climbs after trial shows 55% lower risk in lung disease patients, plans FDA filing in 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.56B

Investing Cash Flow (TTM)

-551.30M

Financing Cash Flow (TTM)

-1.15B

Free Cash Flow (TTM)

1.04B

Capital Expenditure (TTM)

-526.00M

Net Change in Cash (TTM)

-140.10M

Analyst Trends and Forecast

2

Oct 25

1

Nov 25

1

Jan

4

1

Feb

4

3

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$21.41B

PE Ratio (TTM)

20.27

PE Ratio (FWD)

20.04

PEG Ratio (TTM)

2.25

PS Ratio (TTM)

8.50

PB Ratio (TTM)

3.49

Earnings Yield % (TTM)

4.93%

Earnings Yield % (FWD)

4.99%

EV / EBITDA (TTM)

11.89

Price / EBITDA (TTM)

14.87

Price / Free Cash Flow (TTM)

26.13

Book Value / Share

$161.91

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.56B

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$500.00M

Key Statistics

Open

$566.14

Close

$559.65

Volume / Avg.

504.98K / 496.34K

Day Range

$552.54 - $567.39

52 Wk Range

266.98 - 607.89

Market Cap

$24.10B

P/E Ratio

20.27

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.81%

Days to Cover

4.09

About

Sector

Health Care

Industry

Biotechnology

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry